Pharma Majors Surge into Nutrition as Weight Loss Frenzy Demands Metabolic Support
India's battle against obesity and diabetes is undergoing a massive transformation, with pharmaceutical giants strategically pivoting to dominate the nutrition segment supporting GLP-1 therapies. Companies like Dr Reddy's, Abbott India, Zydus, Mankind Pharma, and Sun Pharma are rapidly building extensive ecosystems of nutritional products, protein supplements, and patient support services designed to complement advanced GLP-1 anti-diabetes and weight loss medicines.This strategic shift reflects a crucial understanding that sustained metabolic health requires more than simply appetite-suppressing injections. Unlike older chronic disease treatments, these...